Jul 1, 2026 07:00AM
Jul 1, 2026 07:00AM
Jul 1, 2026 07:00AM
Jul 1, 2026 07:00AM
Jun 10, 2026 07:01AM
Jun 10, 2026 07:00AM
May 11, 2026 04:05PM Harrow Announces First Quarter 2026 Financial Results
Apr 16, 2026 07:00AM
Mar 19, 2026 06:59AM
Mar 18, 2026 07:00AM
Mar 3, 2026 03:15PM
Mar 3, 2026 07:02AM
Mar 3, 2026 07:00AM
Mar 2, 2026 04:05PM Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance
Feb 17, 2026 07:00AM
Feb 3, 2026 05:00AM
Nov 18, 2025 07:01AM
Nov 18, 2025 07:00AM
Nov 10, 2025 04:05PM
Oct 6, 2025 07:00AM
Oct 6, 2025 07:00AM ImprimisRx Announces Leadership Changes
Sep 26, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 23, 2025 06:45AM
Aug 11, 2025 04:01PM
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States
Jun 11, 2025 04:25PM
Jun 9, 2025 07:03AM
Jun 9, 2025 07:00AM
May 8, 2025 04:01PM
Apr 10, 2025 07:00AM
Mar 27, 2025 04:01PM
Mar 24, 2025 07:05AM Harrow Health (HROW) Announces Transitional Pass-Through Reimbursement Status for TRIESENCE 40 mg/mL
Mar 24, 2025 07:00AM
Mar 11, 2025 07:00AM
Feb 6, 2025 08:44AM
Jan 7, 2025 07:01AM
Jan 7, 2025 07:00AM
Nov 22, 2024 01:51PM
Nov 20, 2024 07:00AM Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery
Oct 18, 2024 06:10AM
Oct 10, 2024 07:00AM
Oct 3, 2024 07:02AM
Oct 3, 2024 07:00AM
Jul 29, 2024 08:00AM
Jul 9, 2024 07:02AM
Jul 9, 2024 07:00AM Harrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow Products
Jun 20, 2024 07:04AM

324,763 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All